PhoenixBio Co (TSE:6190) Scaled Net Operating Assets: 0.42 (As of Mar. 2026)


TSE:6190 PhoenixBio Co Ltd TSE:6190
55 GF Score
Price 円337.00
GF Value 円358.63
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is PhoenixBio Co Scaled Net Operating Assets?

PhoenixBio Co TSE:6190 +2.43% 55 Scaled Net Operating Assets is 0.42 as of Mar. 2026. GuruFocus rates TSE:6190 with a GF Score™ of 55/100 and a GF Value™ of 円358.63 (Fairly Valued). The stock has 5 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

PhoenixBio Co's operating assets for the quarter that ended in Mar. 2026 was 円1,044 Mil. PhoenixBio Co's operating liabilities for the quarter that ended in Mar. 2026 was 円153 Mil. PhoenixBio Co's Total Assets for the quarter that ended in Sep. 2025 was 円2,101 Mil. Therefore, PhoenixBio Co's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was 0.42.


PhoenixBio Co Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for PhoenixBio Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PhoenixBio Co Scaled Net Operating Assets Chart

PhoenixBio Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.22 0.48 0.38 0.29 0.39

PhoenixBio Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.36 0.34 0.31 0.36 0.42

TSE:6190 vs VRTX, REGN, ALNY: Scaled Net Operating Assets Comparison

For the Biotechnology subindustry, PhoenixBio Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PhoenixBio Co Scaled Net Operating Assets vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PhoenixBio Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where PhoenixBio Co's Scaled Net Operating Assets falls into.


TSE:6190
55GF Score
PhoenixBio Co Ltd TSE:6190
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PhoenixBio Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

PhoenixBio Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(A: Mar. 2026 )
=(Operating Assets (A: Mar. 2026 )-Operating Liabilities (A: Mar. 2026 ))/Total Assets (A: Mar. 2025 )
=(1044.488-153.413)/2285.342
=0.39

where

Operating Assets(A: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=2192.682 - 1148.194
=1044.488

Operating Liabilities(A: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=640.055 - 266.575 - 220.067
=153.413

PhoenixBio Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2026 )
=(Operating Assets (Q: Mar. 2026 )-Operating Liabilities (Q: Mar. 2026 ))/Total Assets (Q: Sep. 2025 )
=(1044.488-153.413)/2101.006
=0.42

where

Operating Assets(Q: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=2192.682 - 1148.194
=1044.488

Operating Liabilities(Q: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=640.055 - 266.575 - 220.067
=153.413

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of 0.42 mean?
PhoenixBio Co (TSE:6190) has a Scaled Net Operating Assets of 0.42 as of Mar. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on PhoenixBio Co and its competitors.
Is PhoenixBio Co's Scaled Net Operating Assets too high?
PhoenixBio Co's current Scaled Net Operating Assets is 0.42. Overall, PhoenixBio Co has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PhoenixBio Co's Scaled Net Operating Assets compare to VRTX and REGN?
PhoenixBio Co's Scaled Net Operating Assets of 0.42 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Biotechnology company?
A good Scaled Net Operating Assets depends on the Biotechnology industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on PhoenixBio Co and its competitors. PhoenixBio Co's current Scaled Net Operating Assets is 0.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PhoenixBio Co stock overvalued right now?
Based on GuruFocus' analysis, PhoenixBio Co (TSE:6190) is currently considered Fairly Valued. The stock's GF Value™ is 円358.63, compared to a current price of 円337.00 — trading 6% below its estimated fair value. The current Scaled Net Operating Assets is 0.42. PhoenixBio Co's overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For PhoenixBio Co (TSE:6190), the current Scaled Net Operating Assets is 0.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PhoenixBio Co (TSE:6190) Overvalued in 2026?

Based on GuruFocus' analysis, PhoenixBio Co stock appears to be undervalued. The current stock price of 円337.00 is trading 6% below its estimated GF Value™ of 円358.63. GuruFocus considers PhoenixBio Co to be Fairly Valued.

Key valuation signals for TSE:6190:

  • Scaled Net Operating Assets: 0.42
  • GF Value™: 円358.63 vs. price of 円337.00 (6% below fair value)
  • GF Score™: 55/100 with 5 warning signs

No single metric tells the full story. See the TSE:6190 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PhoenixBio Co Business Description

Address 3-4-1, Kagamiyama, Hiroshima Prefecture, Higashi-Hiroshima, JPN, 739-0046
PhoenixBio Co Ltd conducts study services for drug discovery and early development. It provides outsourcing services for drug development. The Company uses PXB-Mouse to conduct the study. Its services include pharmacokinetics-related tests, safety tests, and hepatitis virus (HBV / HCV) related drug efficacy tests. Geographically, the company generates the majority of its revenue from USA.
55GF Score

Get the complete analysis for TSE:6190

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円337.00
Price
円358.63
GF Value